Cuiping Yang
Nanjing, 210009, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 10 publications
Target therapy of multiple myeloma by PTX-NPs and ABCG2 antibody in a mouse xenograft model.
Journal: Oncotarget
Published: May 01, 2015
Gamma-Fe2O3 nanoparticles increase therapeutic efficacy of combination with paclitaxel and anti-ABCG2 monoclonal antibody on multiple myeloma cancer stem cells in mouse model.
Journal: Journal of biomedical nanotechnology
Published: April 18, 2014
Effect of down-regulated transcriptional repressor ZEB1 on the epithelial-mesenchymal transition of ovarian cancer cells.
Journal: International journal of gynecological cancer : official journal of the International Gynecological Cancer Society
Published: November 22, 2013
Observation of ovarian cancer stem cell behavior and investigation of potential mechanisms of drug resistance in three-dimensional cell culture.
Journal: Journal of bioscience and bioengineering
Published: July 29, 2013
MicroRNA-200c overexpression inhibits tumorigenicity and metastasis of CD117+CD44+ ovarian cancer stem cells by regulating epithelial-mesenchymal transition.
Journal: Journal of ovarian research
Published: May 16, 2013
Paclitaxel-Fe3O4 nanoparticles inhibit growth of CD138(-) CD34(-) tumor stem-like cells in multiple myeloma-bearing mice.
Journal: International journal of nanomedicine
Published: April 24, 2013
Anti-ABCG2 monoclonal antibody in combination with paclitaxel nanoparticles against cancer stem-like cell activity in multiple myeloma.
Journal: Nanomedicine (London, England)
Published: March 29, 2013
Evaluation of characteristics of CD44+CD117+ ovarian cancer stem cells in three dimensional basement membrane extract scaffold versus two dimensional monocultures.
Journal: BMC cell biology
Published: September 28, 2012
Downregulation of gene MDR1 by shRNA to reverse multidrug-resistance of ovarian cancer A2780 cells.
Journal: Journal of cancer research and therapeutics
Published: July 31, 2012
Antitumor efficacy of viable tumor vaccine modified by heterogenetic ESAT-6 antigen and cytokine IL-21 in melanomatous mouse.
Journal: Immunologic research
Published: April 06, 2012
Showing 1-10 of 10
Last Updated: 09/26/2026